Richard Bird
Neurology · Salisbury, MDNPI 1265435473
Payments from drug & device makers
Across 434 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$999
- Biohaven Pharmaceuticals, Inc.$671
- AbbVie$571
- Biohaven Pharmaceutical Holding Company Ltd.$522
- Amgen$497
- Biogen$348
- plus $3K from 34 others
What the payments were for
- Food & beverage$6,99099%
- Education$531%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 52 | $999 |
| Biohaven Pharmaceuticals, Inc. | 68 | $671 |
| AbbVie | 48 | $571 |
| Biohaven Pharmaceutical Holding Company Ltd. | 48 | $522 |
| Amgen(2 entities) | 21 | $497 |
| Biogen | 19 | $348 |
| Lilly USA, LLC | 19 | $329 |
| Neurocrine Biosciences, Inc. | 12 | $300 |
| Eisai Inc. | 15 | $257 |
| Sunovion Pharmaceuticals Inc. | 15 | $229 |
| EMD Serono, Inc. | 9 | $213 |
| Lundbeck LLC | 10 | $210 |
| Novartis | 13 | $209 |
| UCB, Inc. | 9 | $173 |
| Argenx US, Inc. | 6 | $163 |
| Tanabe Pharma America, Inc. | 8 | $153 |
| Bristol Myers Squibb | 9 | $145 |
| CSL Behring | 6 | $138 |
| Sanofi | 6 | $104 |
| AstraZeneca | 4 | $94 |
| E.r. Squibb & Sons, L.L.C. | 6 | $87 |
| Abbott | 1 | $86 |
| Grifols USA, LLC | 4 | $74 |
| Neurelis, Inc. | 4 | $66 |
| Octapharma USA, Inc. | 1 | $61 |
| Pfizer | 3 | $47 |
| Boston Scientific | 2 | $45 |
| Adamas Pharmaceuticals, Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Livanova USA, Inc. | 2 | $31 |
| Johnson & Johnson | 1 | $24 |
| Genentech USA, Inc. | 1 | $18 |
| Acorda Therapeutics, Inc | 1 | $17 |
| Insightec,inc | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Impel Pharmaceuticals Inc. | 1 | $15 |
| Avion Pharmaceuticals | 1 | $12 |
| Azurity Pharmaceuticals, Inc. | 1 | $12 |
| Sumitomo Pharma America, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,043 in reported general payments places this provider in the 60th percentile of 442 neurology providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 14 | $155,514 |
| Levetiracetam | 51 | $2,191 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 22 | $892 |
| Divalproex Sodium ErDivalproex Sodium | 13 | $799 |
| Topiramate | 33 | $637 |
| Gabapentin | 24 | $426 |
| Donepezil Hcl | 36 | $379 |
| Primidone | 11 | $281 |
| Clonazepam | 17 | $158 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Grifols USA, LLCGamunex-C | $74 | $155,51414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 442 neurology providers in Maryland.
Other neurology in Salisbury
- Jose MasdeuBethesda$5.8M
- Ellen MowryBaltimore$5.7M
- Daniel BeckerLutherville$4.2M
- Michael PolydefkisBaltimore$4.1M
- Pavel KleinBethesda$3.2M
- Jeffrey RothsteinBaltimore$3M
- Pavan BhargavaBaltimore$2.8M
- Thomas CrawfordBaltimore$2.4M
- Nicholas MaragakisBaltimore$2.2M
- Shiv SaidhaBaltimore$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.